Inhibition of human glutathione reductase by S-nitrosoglutathione
- PMID: 8536691
- DOI: 10.1111/j.1432-1033.1995.472_b.x
Inhibition of human glutathione reductase by S-nitrosoglutathione
Abstract
S-Nitrosoglutathione (GSNO) represents a major transport form in nitric oxide (NO) in biological systems. Since NO and GSNO have been shown to modulate the function of various proteins, we studied the influence of GSNO and other NO donors on human glutathione reductase (GR). Catalyzing the reaction NADPH+GSSG+H(+)-->NADP(+) + 2 GSH, the dimeric flavoprotein GR is the central enzyme of the glutathione redox metabolism. GSNO was found to inhibit crystalline erythrocyte GR in two ways: (a) as a reversible inhibitor GSNO is competitive with glutathione disulfide (GSSG), the Ki being appr. 0.5 mM; (b) as an irreversible inhibitor; after 1 h (3 h) incubation with 1 mM GSNO, GR (2.5 U/ml, representing intraerythrocytic concentrations) was inhibited by 70% (90%). This inhibition depended on the presence of NADPH and could not be reversed by dilution nor by reducing agents. Absorption spectra indicate that the charge-transfer interaction between Cys63 and the flavin is abolished by this modification. In a GR sample inhibited by 90% with GSNO, the Km values for the substrates GSSG and NADPH were not significantly changed nor did the modification induce oxidase activity of the enzyme. GSNO was found not to be a substrate in the forward reaction of GR. This implies that GSNO is not accounted for by methods which employ GR for determining total glutathione. Incubating isolated GR for 60 min with other NO donors, namely 1 mM sodium nitroprusside or 1 mM S-nitroso-N-acetyl-DL-penicillamine (SNAP), resulted in only 25% and 10% inhibition, respectively. This attests to a specific affinity of GSNO to the enzyme. GSNO inhibition patterns comparable to purified authentic GR were obtained for purified recombinant GR, a GR mutant lacking the 15 N-terminal amino acids including Cys2, and for the enzyme present in diluted fresh haemolysates (0.02 U/ml); in concentrated haemolysates the inhibition was less pronounced. GR of intact erythrocytes was not affected when exposed to GSNO in the medium. Our results suggest that the irreversible inhibition of GR by GSNO involves nitrosylation of Cys63 and/or Cys58 at the catalytic site of the enzyme. To further investigate the mechanism of inactivation we have crystallized GSNO-modified GR for X-ray diffraction analysis.
Similar articles
-
Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase.Biochem Pharmacol. 1997 Dec 15;54(12):1307-13. doi: 10.1016/s0006-2952(97)00348-1. Biochem Pharmacol. 1997. PMID: 9393673
-
Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid.Biochemistry. 1999 Oct 12;38(41):13574-83. doi: 10.1021/bi991028u. Biochemistry. 1999. PMID: 10521264
-
Modification of aldose reductase by S-nitrosoglutathione.Biochemistry. 1997 Dec 16;36(50):15801-9. doi: 10.1021/bi9714722. Biochemistry. 1997. PMID: 9398310
-
The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications.Free Radic Res. 1999 Dec;31(6):641-50. doi: 10.1080/10715769900301211. Free Radic Res. 1999. PMID: 10630687 Review.
-
Neuroprotective properties of nitric oxide.Ann N Y Acad Sci. 1999;890:301-11. doi: 10.1111/j.1749-6632.1999.tb08007.x. Ann N Y Acad Sci. 1999. PMID: 10668435 Review.
Cited by
-
Sirtuin Oxidative Post-translational Modifications.Front Physiol. 2021 Nov 24;12:763417. doi: 10.3389/fphys.2021.763417. eCollection 2021. Front Physiol. 2021. PMID: 34899389 Free PMC article. Review.
-
Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarate.Sci Rep. 2016 Jun 29;6:28754. doi: 10.1038/srep28754. Sci Rep. 2016. PMID: 27353740 Free PMC article.
-
Deregulation of hepatic insulin sensitivity induced by central lipid infusion in rats is mediated by nitric oxide.PLoS One. 2009 Aug 14;4(8):e6649. doi: 10.1371/journal.pone.0006649. PLoS One. 2009. PMID: 19680547 Free PMC article.
-
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.J Transl Med. 2008 Feb 26;6:9. doi: 10.1186/1479-5876-6-9. J Transl Med. 2008. PMID: 18302761 Free PMC article.
-
Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione.J Biol Chem. 2009 Jan 30;284(5):2729-2737. doi: 10.1074/jbc.M802683200. Epub 2008 Dec 2. J Biol Chem. 2009. PMID: 19049979 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources